# US 2022/0044822 A1 · System for the ovarian reserve function assessment of subjects

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0044822 A1
- Document ID: US20220044822A1
- Status: Published application
- Kind: A1
- Application number: 17/413,182
- Filed: 2018-12-28
- Published: 2022-02-10
- Earliest claimed: 2018-12-12
- Assignees: Guangzhou Kangrun Biotech Co., Ltd
- Applicants: Guangzhou Kangrun Biotech Co., Ltd
- Inventors: Rong LI; Huiyu XU; Jie QIAO
- Web page: https://patentgrep.com/patent/US20220044822A1

## CPC

- G16H 50/30: for calculating health indices; for individual health risk assessment
- A61B 5/4325: {of the uterine cavities, e.g. uterus, fallopian tubes, ovaries}
- G01N 33/689: {related to pregnancy or the gonads}
- G01N 33/76: Human chorionic gonadotropin {including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors}
- G06F 17/18: for evaluating statistical data {, e.g. average values, frequency distributions, probability functions, regression analysis (forecasting specially adapted for a specific administrative, business or logistic context G06Q10/04)}
- A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor}
- A61B 8/0866: {involving foetal diagnosis; pre-natal or peri-natal diagnosis of the baby}
- A61B 8/12: in body cavities or body tracts, e.g. by using catheters
- A61B 8/4416: {related to combined acquisition of different diagnostic modalities, e.g. combination of ultrasound and X-ray acquisitions}
- A61B 8/5223: {for extracting a diagnostic or physiological parameter from medical diagnostic data (for algorithms to analyse biomedical images G06T7/0012)}
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G06F: ELECTRIC DIGITAL DATA PROCESSING (computer systems based on specific computational models G06N)

## Abstract

A system and a method for assessing the ovarian reserve function of a subject. The system for assessing a subject's ovarian reserve function comprises: a data acquisition module configured to acquire data of the subject's age, anti-Müllerian hormone (AMH) level, follicle stimulating hormone (FSH) level, and antral follicle count (AFC); and an ovarian reserve function calculation module configured to calculate the above-mentioned information acquired in the data acquisition module, so as to work out the subject's probability of poor ovarian response (p). Further, the population is divided into four groups according to the interaction relationship between the predicted probability of poor ovarian response and the dose of ovulation stimulants, so as to divide the population with similar ovarian responses into one group.

## Claims

### Claim 1

A system for assessing the ovarian reserve function of a subject, comprising:
a data acquisition module configured to acquire data of the subject's age, anti-Müllerian hormone (AMH) level, follicle stimulating hormone (FSH) level, and antral follicle count (AFC); and
an ovarian reserve function calculation module configured to calculate the above-mentioned information acquired in the data acquisition module, so as to work out the subject's probability of poor ovarian response (p).

### Claim 2 (depends on 1)

The system according to claim 1, further comprising:
a grouping module, in which default ovarian reserve function grouping parameters are prestored, and the calculated probability of poor ovary response p is grouped according to the grouping parameters, so as to group the subject's ovarian reserve level.

### Claim 3 (depends on 1)

The system according to claim 1, wherein:
in the ovarian reserve function calculation module, the dichotomous variables transformed from the data of the subject's age, the subject's anti-Müllerian hormone (AMH) level, the subject's follicle stimulating hormone (FSH) level, and the subject's antral follicle count (AFC) are used to calculate the subject's probability of poor ovarian response (p).

### Claim 4 (depends on 3)

The system according to claim 3, wherein:
in the ovarian reserve function calculation module, the receiver operating characteristic (ROC) curve is used to detect the cutoff points of the age, the anti-Müllerian hormone (AMH) level, the follicle stimulating hormone (FSH) level, and the antral follicle count (AFC), and according to the tangent point values of the cutoff points, the age, the anti-Müllerian hormone (AMH) level, the follicle stimulating hormone (FSH) level, and the antral follicle count (AFC) are transformed into dichotomous variables, thereby the dichotomous variables are used to calculate the probability of poor ovarian response (p).

### Claim 5 (depends on 4)

The system of claim 4, wherein:
the anti-Müllerian hormone (AMH) level refers to the anti-Müllerian hormone concentration in the venous blood of a female subject on the 2nd-4th day of menstruation, the follicle stimulating hormone (FSH) level refers to the follicle stimulating hormone concentration in the venous blood of a female subject on the 2nd-4th day of menstruation, and the antral follicle count (AFC) refers to the total number of visible follicles with diameters of 2-8 mm in the two ovaries on the 2nd-4th day of menstruation counted with transvaginal B-scan ultrasonography.

### Claim 6 (depends on 4)

The system according to claim 4, wherein:
the tangent point value of the age is 35 years old, the tangent point value of the anti-Müllerian hormone (AMH) level is 0.93 ng/ml, the tangent point value of the follicle stimulating hormone (FSH) level is 9.1 IU/L, and the tangent point value of the antral follicle count (AFC) is 8.

### Claim 7 (depends on 1)

The system according to claim 1, wherein:
in the ovarian reserve function calculation module, a formula for calculating the subject's probability of poor ovarian response (p) is pre-stored, wherein the formula is fitted with dichotomous variables transformed from the data of the subject's age, the subject's anti-Müllerian hormone (AMH) level, the subject's follicle stimulating hormone (FSH) level, and the subject's antral follicle count (AFC) in an exiting database.

### Claim 8 (depends on 7)

The system according to claim 7, wherein:
the formula is the following formula 1:
p
=
1
1
+
e
-
(
i
+
a
*
age
+
b
*
AMH
+
c
*
FSH
+
d
*
AFC
)
(
Formula
⁢
⁢
1
)
wherein, p is a calculated parameter used to characterize the subject's ovarian reserve function, i is any numeric value selected from −1.786 to −0.499, a is any numeric value selected from 0.063 to 1.342, b is any numeric value selected from −2.542 to −1.056, c is any numeric value selected from 0.548 to 1.838, and d is any numeric value selected from −2.133 to −0.51, wherein preferably I=−1.143, preferably a=0.703, preferably b=−1.799, preferably c=1.193, and preferably d=−1.322.

### Claim 9 (depends on 2)

The system according to claim 2, wherein:
the grouping parameter pre-stored in the grouping module are:
when the calculated subject's probability of poor ovarian response (p) is <5%, the grouping module determines that the subject's ovarian reserve function is good;
when 5%≤the calculated subject's probability of poor ovarian response (p) <20%, the grouping module determines that the subject's ovarian reserve function starts to decline;
when 20%≤the calculated subject's probability of poor ovarian response (p)<50%, the grouping module determines that the subject's ovarian reserve function declines significantly; and
when the calculated subject's probability of poor ovarian response (p) is ≥50%, the grouping module determines that the subject's ovarian reserve function is poor.

### Claim 10

A method for assessing the ovarian reserve function of a subject, comprising:
a data acquisition step, in which the data of the subject's age, anti-Müllerian hormone (AMH) level, follicle stimulating hormone (FSH) level, and antral follicle count (AFC) are acquired; and
an ovarian reserve function calculation step, in which the data of the age, the anti-Müllerian hormone (AMH) level, the follicle stimulating hormone (FSH) level, and the antral follicle count (AFC) acquired in the above data acquisition step are used to calculate the subject's probability of poor ovarian response (p).

### Claim 11 (depends on 10)

The method according to claim 10, wherein:
In the grouping step, the calculated probability of poor ovarian response is grouped according to the default grouping parameters of the ovarian reserve function, so as to group the subject's ovarian reserve level.

### Claim 12 (depends on 10)

The method according to claim 10, wherein:
in the ovarian reserve function calculation step, the data of the subject's age, the subject's anti-Müllerian hormone (AMH) level, the subject's follicle stimulating hormone (FSH) level, and the subject's antral follicle count (AFC) are transformed into dichotomous variables, and the transformed dichotomous variables are used to calculate the subject's probability of poor ovarian response (p).

### Claim 13 (depends on 12)

The method according to claim 12, wherein:
in the probability of poor ovarian response calculation step, the receiver operating characteristic (ROC) curve is used to detect the cutoff points of the age, the anti-Müllerian hormone (AMH) level, the follicle stimulating hormone (FSH) level, and the antral follicle count (AFC), and according to the tangent point values of the cutoff points, the age, the anti-Müllerian hormone (AMH) level, the follicle stimulating hormone (FSH) level, and the antral follicle count (AFC) are transformed into dichotomous variables, thereby the model of the dichotomous variables is used to calculate the subject's probability of poor ovarian response (p).

### Claim 14 (depends on 13)

The method according to claim 13, wherein:
the anti-Müllerian hormone (AMH) level refers to the anti-Müllerian hormone concentration in the venous blood serum of a female subject on the 2nd-4th day of menstruation, the follicle stimulating hormone (FSH) level refers to the follicle stimulating hormone concentration in the venous blood serum of a female subject on the 2nd-4th day of menstruation, and the antral follicle count (AFC) refers to the total number of visible follicles with diameters of 2-8 mm in the two ovaries on the 2nd-4th day of menstruation counted with transvaginal B-scan ultrasonography.

### Claim 15 (depends on 13)

The method according to claim 13, wherein:
the tangent point value of the age is 35 years old, the tangent point value of the anti-Müllerian hormone (AMH) level is 0.93 ng/ml, the tangent point value of the follicle stimulating hormone (FSH) level is 9.1 IU/L, and the tangent point value of the antral follicle count (AFC) is 8.

### Claim 16 (depends on 10)

The method according to claim 10, wherein:
in the ovarian reserve function calculation step, the pre-stored formula for calculating the subject's probability of poor ovarian response (p) is used for the calculation, wherein the formula is fitted with the dichotomous variables transformed from the data of the subject's age, the subject's anti-Müllerian hormone (AMH) level, the subject's follicle stimulating hormone (FSH) level, and the subject's antral follicle count (AFC) in a pre-existing database.

### Claim 17 (depends on 10)

The method according to claim 10, wherein:
in the ovarian reserve function calculation step, the subject's probability of poor ovarian response (p) is calculated using the following formula 1, and according to the data of the age, the anti-Müllerian hormone (AMH) level, the follicle stimulating hormone (FSH) level, and the antral follicle count (AFC) that are acquired in the data acquisition step and have been transformed into dichotomous variables:
p
=
1
1
+
e
-
(
i
+
a
*
age
+
b
*
AMH
+
c
*
FSH
+
d
*
AFC
)
(
Formula
⁢
⁢
1
)
wherein, p is a calculated parameter used to characterize the subject's ovarian reserve function, i is any numeric value selected from −1.786 to −0.499, a is any numeric value selected from 0.063 to 1.342, b is any numeric value selected from −2.542 to −1.056, c is any numeric value selected from 0.548 to 1.838, and d is any numeric value selected from −2.133 to −0.51, wherein preferably I=−1.143, preferably a=0.703, preferably b=−1.799, preferably c=1.193, and preferably d=−1.322.

### Claim 18 (depends on 11)

The method according to claim 11, wherein:
the pre-stored basis for grouping in the grouping module is:
when the calculated subject's probability of poor ovarian response (p)<5%, the grouping module determines that the subject's ovarian reserve function is good;
when 5%≤the calculated subject's probability of poor ovarian response (p)<20%, the grouping module determines that the subject's ovarian reserve function starts to decline;
when 20%≤the calculated subject's probability of poor ovarian response (p)<50%, the grouping module determines that the subject's ovarian reserve function declines significantly; and
when the calculated subject's probability of poor ovarian response (p) is ≥50%, the grouping module determines that the subject's ovarian reserve function is poor.
